General Announcement

6 November 2026 To To National Stock Exchange of India Limited, BSE Limited Exchange Plaza, Bandra Kurla Complex, 25th floor, P. J. Towers, Bandra (E), Mumbai – 400 051 Dalal Street, Mumbai – 400 001 Scrip Symbol: COHANCE Scrip Code – 543064 Dear Sir/Madam, Sub: TGPCB order directing closure of operations at the Company’s manufacturing site at Suryapet Pursuant to Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“SEBI Listing Regulations”) we wish to inform you that the Company has received an order from the Telangana Pollution Control Board (“TGPCB”) directing closure of operations at the Company’s manufacturing site at Suryapet, Telangana. The closure order has been issued following an industrial accident that occurred during the manufacturing process, resulting in exposure to one employee on duty at the facility. The employee was immediately provided emergency medical assistance and was subsequently shifted to a specialized hospital in Hyderabad for advanced treatment. Despite receiving the best possible medical care and sustained efforts by the attending medical teams, the employee unfortunately succumbed to his injuries. The Company has immediately initiated appropriate corrective and preventive measures to address the observations stated in the directions issued by TGPCB and expects to promptly submit the requisite representations and compliances to TBPCB, for seeking cancellation of the closure directions at the earliest and allowing the site to resume operations. The Company will keep the Stock Exchanges informed of any material developments in this regard. The details required under Regulation 30 read with Clause 20 of Para A of Part A of Schedule III of the SEBI Listing Regulations and the SEBI Master Circular dated 30 January 2026 are enclosed as Annexure I. The disclosure containing details of the communication received from TGPCB , as required under Regulation 30(13) of the SEBI Listing Regulations read with the Industry Standards prescribed by the Industry Standards Forum (ISF), is enclosed as Annexure II. This is for your information and record. Thank you. Yours faithfully, For Cohance Lifesciences Limited (formerly, Suven Pharmaceuticals Limited) Sisir K Mishra Company Secretary and Compliance Officer Encl: As above Annexure - I Disclosure under Regulation 30 of the SEBI Listing Regulations and SEBI Master Circular dated 30 January 2026 Name of the authority; Telangana State Pollution Control Board (TGPCB) Nature and details of the action(s) taken or Closure order directing the Company to suspend order(s) passed; manufacturing activities at the Suryapet manufacturing site with immediate effect. Date of receipt of direction or order, including any 5 November 2026 ad-interim or interim orders, or any other communication from the authority; Details of the violation(s)/contravention(s) The Telangana State Pollution Control Board committed or alleged to be committed; (TGPCB) conducted an inspection of the facility following an industrial accident at the Suryapet manufacturing site which lead to the eventual demise of an employee and identified certain alleged non- compliances with the applicable consent conditions. TGPCB has consequently issued a closure order directing the Company to suspend manufacturing activities at the Suryapet manufacturing site with immediate effect. Impact on financial, operation or other activities The Company is assessing the operational and of the listed entity, quantifiable in monetary terms financial impact of the closure. At this stage, the to the extent possible. impact cannot be quantified with reasonable certainty. Annexure – II 6 November 2026 To To National Stock Exchange of India Limited, BSE Limited Exchange Plaza, Bandra Kurla Complex, 25th floor, P. J. Towers, Bandra (E), Mumbai – 400 051 Dalal Street, Mumbai – 400 001 Scrip Symbol: COHANCE Scrip Code – 543064 Dear Sir/Madam, Sub: TGPCB order directing closure of operations at the Company’s manufacturing site at Suryapet In respect of the captioned matter, I, the undersigned, state and declare that the information and details provided in Form A, in compliance with Regulation 30(13) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, is true, correct and complete to the best of my knowledge and belief. This is for your information and records. Thanking you, Yours faithfully, For Cohance Lifesciences Limited (formerly, Suven Pharmaceuticals Limited) Sisir K Mishra Company Secretary and Compliance Officer Form A Disclosure regarding receipt of communication from regulatory, statutory, enforcement or judicial authority under the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 S. Particulars Details 1 Name of the listed company Cohance Lifesciences Limited (formerly, Suven Pharmaceuticals Limited) 2 Type of communication received Closure Order 3 Date of receipt of communication 5 November 2026 4 Authority from whom communication Telangana State Pollution Control Board (TGPCB) received 5 Brief summary of the material contents of the Telangana State Pollution Control Board (TGPCB) communication received, including reasons has identified certain alleged non-compliances for for receipt of the communication implementation of safety measures, in line with the applicable consent conditions. 6 Period for which communication would be Immediate applicable, if stated 7 Expected financial implications on the listed The Company is assessing the operational and company, if any financial impact of the closure. At this stage, the impact cannot be quantified with reasonable certainty. 8 Details of any aberrations/non-compliances Lack of strict implementation of safety measures for identified by the authority in the prevention of the accident, in line with the communication applicable consent conditions. 9 Details of any penalty or restriction or Closure Order sanction imposed pursuant to the communication 10 Action(s) taken by listed company with The Company has immediately initiated appropriate respect to the communication corrective and preventive measures to address the observations stated in the directions issued by TGPCB and expects to promptly submit the requisite representations and compliances to TBPCB, for seeking cancellation of the closure directions at the earliest and allowing the site to resume operations. 11 Any other relevant information Nil